4 unchanged sentences
001-37581), filed with the SEC on June 24, 2020).
−Removed: Employment Agreement, dated as of August 1, 2022, by and between the Registrant and Douglas Manion (incorporated herein by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K (File No.
−Removed: 001-37581), filed with the SEC on August 1, 2022).
+Added: Amended and Restated Employment Agreement, dated as of January 1, 2023, by and between the Registrant and Douglas Manion (incorporated herein by reference to Exhibit 10.23 to the Registrant’s Annual Report on Form 10-K (File No.
+Added: 001-37581), filed with the SEC on February 23, 2023).
+Added: Employment Agreement, dated as of January 1, 2023, by and between the Registrant and Kevin Balthaser (incorporated herein by reference to Exhibit 10.24 to the Registrant’s Annual Report on Form 10-K (File No.
+Added: 001-37581), filed with the SEC on February 23, 2023).
+Added: Eighth Amended and Restated Non-Employee Director Compensation Policy (incorporated herein by reference to Exhibit 10.12 to the Registrant’s Annual Report on Form 10-K (File No.
+Added: 001-37581), filed with the SEC on February 23, 2023).
+Added: Ninth Amended and Restated Non-Employee Director Compensation Policy.
+Added: Consulting Agreement, dated as of January 1, 2023, by and between the Registrant and Frank Ruffo (incorporated herein by reference to Exhibit 10.19 to the Registrant’s Annual Report on Form 10-K (File No.
+Added: 001-37581), filed with the SEC on February 23, 2023).
+Added: Amendment No.
+Added: 1 to Consulting Services Agreement, dated as of March 23, 2023, by and between the Registrant and Frank Ruffo (incorporated herein by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K (File No.
+Added: 001-37581), filed with the SEC on March 27, 2023).
+Added: Sales Agreement, dated as of February 23, 2023, by and among the Registrant, SVB Securities LLC and Cantor Fitzgerald & Co.
+Added: (incorporated herein by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K (File No.
+Added: 001-37581), filed with the SEC on February 23, 2023).
Certification of Principal Executive Officer under Section 302 of the Sarbanes-Oxley Act.
14 unchanged sentences
ACLARIS THERAPEUTICS, INC.
−Removed: November 8, 2022
−Removed: /s/ Neal Walker
−Removed: Chief Executive Officer
+Added: /s/ Douglas Manion
+Added: Douglas Manion
+Added: President and Chief Executive Officer
(On behalf of the Registrant)
−Removed: November 8, 2022
−Removed: /s/ Frank Ruffo
+Added: /s/ Kevin Balthaser
+Added: Kevin Balthaser
Chief Financial Officer
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.